Population pharmacokinetic analysis of esomeprazole in Japanese subjects with various CYP2C19 phenotypes

M Nagase, H Shimada, M Nii, S Ueda… - Journal of Clinical …, 2020 - Wiley Online Library
What is known and objective Esomeprazole, the S‐isomer of omeprazole, is a proton pump
inhibitor which has been approved by over 125 countries, also known as NEXIUM® …
被引用次数：7 相关文章

Population pharmacokinetic analysis of esomeprazole in Japanese subjects with various CYP2C19 phenotypes.

M Nagase, H Shimada, M Nii, S Ueda… - Journal of Clinical …, 2020 - europepmc.org
Methods In this study, a population PK model describing the PK of esomeprazole was
developed to understand the difference of CYP2C19 phenotypes on clearance in the …

Population pharmacokinetic analysis of esomeprazole in Japanese subjects with various CYP2C19 phenotypes.

M Nagase, H Shimada, M Nii, S Ueda… - Journal of Clinical …, 2020 - search.ebscohost.com
What is known and objective: Esomeprazole, the S‐isomer of omeprazole, is a proton pump
inhibitor which has been approved by over 125 countries, also known as NEXIUM® …

Population pharmacokinetic analysis of esomeprazole in Japanese subjects with various CYP2C19 phenotypes

M Nagase, H Shimada, M Nii… - Journal of clinical …, 2020 - pubmed.ncbi.nlm.nih.gov
What is known and objective Esomeprazole, the S-isomer of omeprazole, is a proton pump
inhibitor which has been approved by over 125 countries, also known as NEXIUM® …